What We're Reading: California Drug Price Transparency Bill Pulled
What we're reading, August 18, 2016: California drug price transparency bill gets pulled; researchers work on a new opioid painkiller without the addiction; and the need for more diversity in genetic sequencing.
A California senator has withdrawn his bill that would require drug makers explain steep price hikes.
Researchers are trying to create a new opioid painkiller that does not cause addiction that leads to deadly overdoses. Scientists have discovered PZM21, a chemical that turns the opioid receptor on without negative effects,
Genetic testing may be more common, but the accuracy of these test results vary based on ethnicity. A new study found that there is a greater need for diversity in genomic research in order to interpret ethnic differences,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025
- Modest Reductions in PrEP Coverage Result in Avoidable HIV Infections
September 17th 2025